VistaGen appoints Reid Adler as Chief Legal Officer effective May 2, 2022

Vistagen Therapeutics, Inc.

Reid G. Adler appointed CLO; will oversee legal affairs and provide strategic guidance to Executive Team and Board.
Adler previously founded Capital Technology Law Group and had represented VistaGen as outside counsel.
Career includes partner at Morrison & Foerster and Morgan Lewis, general counsel at J. Craig Venter Institute.
Adler was founding director of NIH Office of Technology Transfer, building a team of over 40 people.
Company paid Capital Technology Law Group $210,000 in FY ended March 2022 and $18,000 in April 2022 for legal services.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Reid G. Adler

Chief Legal Officer

VTGN · Vistagen Therapeutics, Inc.

Effective: 2022-05-02
Filed: May 3, 2022, 7:59 PM ET

On May 2, 2022, the Board of Directors (the “ Board ”) of VistaGen Therapeutics, Inc. (the “ Company ”), appointed Mr. Reid G. Adler, age 67, as the Company’s Chief Legal Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Reid G. Adler was appointed as Chief Legal Officer at Vistagen Therapeutics, Inc..

Action: appointed
Role: Chief Legal Officer

Exact text from the filing

On May 2, 2022, the Board of Directors (the “ Board ”) of VistaGen Therapeutics, Inc. (the “ Company ”), appointed Mr. Reid G. Adler, age 67, as the Company’s Chief Legal Officer.

View on SEC.gov

Vistagen Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-22-010697

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.